INHIBITORS OF COMPLEMENT FACTOR C3 AND THEIR MEDICAL USES
Compstatin analogues having improved physicochemical properties, such as increased stability and/or solubility as compared to the 13 amino acid compstatin peptide are described, in particular compstatin analogues that additionally possess useful binding and complement-inhibiting activity. These anal...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
14.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Compstatin analogues having improved physicochemical properties, such as increased stability and/or solubility as compared to the 13 amino acid compstatin peptide are described, in particular compstatin analogues that additionally possess useful binding and complement-inhibiting activity. These analogues have an alkylene bridge between sulphur atoms of cysteine residues and include variants with an isoleucine residue at position 3 in place of the wild type valine residue, which provides compstatin peptides with improved binding and complement-inhibiting activity and also enables the introduction of other modifications, for example modifications that are capable of increasing stability, such as the introduction of lysine or serine at position 11. |
---|---|
Bibliography: | Application Number: US202118016490 |